Attends Healthcare
A European leader in the manufacture and supply of branded and own label incontinence products.
Sector: Healthcare Products
Deal Value: £94 million
Transaction: Capex-led turnaround
Fund: RFII
Exit Date: January 2012
Exit Value: £180 million
Exit Route: Canadian trade buyer (Domtar)
Company website: Attends
